HealthSnap Blog

Remote Glucose Monitoring Through RPM Achieves Medication-Level Improvements Without Starting New Treatment

Written by Wesley Smith, Ph.D. | Oct 23, 2025 5:51:46 PM
 
When we think about managing diabetes, most people picture medications, diet changes, and occasional doctor visits. But what happens when patients receive continuous support—right from home?

In HealthSnap’s Remote Patient Monitoring (RPM) program, patients use a cellular glucometer to track fasting blood glucose (FBG) daily. A licensed clinical care navigator monitors these readings in real time, reaching out when concerning trends appear and connecting monthly to review care goals and reinforce evidence-based lifestyle strategies.

These are not newly diagnosed patients or those just beginning therapy. Every participant had been treated conventionally for diabetes for at least a year before enrolling in the RPM program. While some may have had medication adjustments during the program, none started a new treatment at enrollment—making these results especially meaningful.
 

Across 955 patients who stayed on the program for at least 90 days and began with fasting glucose levels above 125 mg/dL, the results were striking:
  • Average fasting glucose decreased by 28–31 mg/dL (p < 0.0001)
  • This improvement is comparable in magnitude to the effects typically seen with glucose-lowering drugs, yet was achieved through a coordinated care system—not a new prescription.
Even more impressive: among over 1,000 patients who transmitted glucose readings consistently for a year, improvements continued month after month. When analyzed by duration, patients on the program for over 800 days—more than two years—experienced the greatest and most sustained reductions in fasting glucose. This shows a clear, dose–response relationship between program duration and improvement.

That’s remarkable, because in traditional care, diabetes typically worsens over time. Here, patients are improving even as they age.

Sustained glucose reductions of this scale don’t just shift lab values—they represent real-world health impact:
  • Lower A1c levels
  • Reduced risk of kidney disease, blindness, and limb amputations
  • And measurable clinical and financial ROI for healthcare organizations
In short, RPM isn’t just technology—it’s a scalable clinical system that enables meaningful, durable improvements in chronic disease management.

HealthSnap’s data continue to show that when daily monitoring meets proactive care, patients improve—and the healthcare system moves closer to true value-based care.